Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE Small Cap

322.00p
   
  • Change Today:
      2.00p
  • 52 Week High: 470.00
  • 52 Week Low: 166.80
  • Currency: UK Pounds
  • Shares Issued: 100.00m
  • Volume: 220,204
  • Market Cap: £322.00m
  • RiskGrade: 125

Latest ShareCast News

Oxford Biomedica confident as it moves away from vaccine era

By Josh White

Date: Monday 29 Apr 2024

(Sharecast News) - Cell and gene therapy contract development and manufacturing organisation (CDMO) Oxford Biomedica reported stability in its core business on Monday, with a small increase in full-year core revenue for 2023, despite a 36% decrease in total revenue to £89.5m.

Oxford Biomedica shares rise on post-acquisition guidance

By Josh White

Date: Tuesday 05 Mar 2024

(Sharecast News) - Shares in cell and gene therapy specialist Oxford Biomedica were jumping on Tuesday afternoon, after the company updated the market on its medium-term financial guidance.

Director dealings: TUI, Oxford Biomedica board members linked to buys

By Josh White

Date: Wednesday 27 Sep 2023

(Sharecast News) - TUI was among those on the list of director buys on Wednesday after its chief executive officer purchased almost 50,000 shares.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 322.00p
Change Today 2.00p
% Change 0.63 %
52 Week High 470.00
52 Week Low 166.80
Volume 220,204
Shares Issued 100.00m
Market Cap £322.00m
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
27.13% below the market average27.13% below the market average27.13% below the market average27.13% below the market average27.13% below the market average
21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average21.57% above the sector average
Price Trend
3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average3.01% below the market average
48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average48.15% above the sector average
Income Not Available
Growth
52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average52.21% below the market average
58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average58.82% below the sector average

What The Brokers Say

Strong Buy 1
Buy 3
Neutral 6
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 15-May-2024

Time Volume / Share Price
16:35 25,047 @ 322.00p
16:35 87 @ 322.00p
16:35 36 @ 322.00p
16:35 36 @ 322.00p
16:35 22 @ 322.00p

OXB Key Personnel

CFO Stuart Paynter
CEO Frank Mathias

Top of Page